Home›Companies›Biotech & Pharma›Gnosko Bio

Gnosko Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 1, 2024·Suggest an edit

About Gnosko Bio

Gnosko Bio is a private company based in Wayne, Pennsylvania, incorporated in 2024 in Delaware. It has reported $100,000 raised in one offering on Form D since July 2024. Its chief executive is William Wendel.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 1, 2024Jul 1, 2024$100,000of $1.7M target2$50,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Gnosko Bio's Form D filed Jul 1, 2024.

SA
Sam Agris
Executive officer and director
DB
Danielle Brady
Executive officer and director
WW
William Wendel
Chief Executive Officer and director
GC
George Cokenakes
Executive officer and director

Sources

  1. SECGnosko Bio Inc. filing history